Skip to content
CardioPharmaGENET
  • About
  • Action StructureExpand
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
  • NewsExpand
    • Events
    • Scientific Activities & Opportunities
    • Open Calls
    • Mobilities
  • DeliverablesExpand
    • All Deliverables
    • Newsletters
    • Publications
  • Contact
Instagram Linkedin YouTube
CardioPharmaGENET

Publications

Explore scientific publications produced within the CardioPharmaGENET network, including research articles, reviews, and evidence-based outputs that contribute to advancing pharmacogenomics in cardiovascular medicine.

  • CardioPharmaGENET Featured in the European Heart Journal
    Publications

    CardioPharmaGENET Featured in the European Heart Journal

    Read More CardioPharmaGENET Featured in the European Heart JournalContinue

  • CardioPharmaGENET (CA24165): A COST Action network for advancing cardiovascular pharmacogenomics and precision medicine Memorandum of Understanding
    Publications

    CardioPharmaGENET (CA24165): A COST Action network for advancing cardiovascular pharmacogenomics and precision medicine Memorandum of Understanding

    Read More CardioPharmaGENET (CA24165): A COST Action network for advancing cardiovascular pharmacogenomics and precision medicine Memorandum of UnderstandingContinue

  • Publications

    First scientific CardioPharmaGENET publication explores the cost-effectiveness of pharmacogenomics-guided cardiovascular treatment

    Read More First scientific CardioPharmaGENET publication explores the cost-effectiveness of pharmacogenomics-guided cardiovascular treatmentContinue

What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu

Privacy policy https://cardiopharmagenet.eu/privacy-policy/

CardioPharmaGENET - CA24165

CardioPharmaGENET COST Action will establish a pan-European network for cardiovascular pharmacogenomics and personalized medicine.

Action Details

MoU – 074/25
CSO Approval date – 19/05/2025
Start date – 29/10/2025
End date – 28/10/2029

How can I participate?

Visit COST webpage
Read the Project Description MoU
Inform the Main Proposer/Chair of your interest (email)
Apply to join your Working Groups (WGs) of interest
Management Committee nominations are carried out through the COST National Contact Points

© 2026 CardioPharmaGENET COST Action CA24165 • Network for Cardiovascular Pharmacogenomics and Precision Medicine

All rights reserved. This website is based upon work from COST Action CA24165 CardioPharmaGENET, supported by COST (European Cooperation in Science and Technology).

Designed by: The Simple

  • About
  • Action Structure
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
  • News
    • Events
    • Scientific Activities & Opportunities
    • Open Calls
    • Mobilities
  • Deliverables
    • All Deliverables
    • Newsletters
    • Publications
  • Contact